Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferinject in Anemic Patients Anticipating Pancreatoduodenectomy
NCT02628860Phase 2Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jan 2014
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Jan 2014; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02628860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02628860.